The computer was in turn connected to an automated syringe pump (Fresenius Vial Inc., Brezins, France).
Labeled glucose was infused by a Pilot C syringe pump (Fresenius Vial, Brezins, France).
Medication use during the pre-period encompassed any prescription that was filled for an OAD agent, a non-insulin injectable, or an insulin pen, pump, or vial.
Anesthesia was induced and maintained with propofol (target effect site concentration 2.5 3.5 μg/ml) and remifentanil (target effect site concentration 2.5 5.0 ng/ml) using a target controlled infusion (TCI) pump (Orchestra®, Fresenius Vial, Brezins, France).
The concentrations of these compounds in gaseous headspace were found to substantially decrease in comparison to previously developed hydrocarbon pump oil based vials; hence, the amount of standard loaded onto SPME fibers was at most, half that of the previous vial design.
OS was collected in glass capillaries connected to an evacuated sterile vial (peristaltic pump).
Epinephrine (diluted to 1 10 in 0.9% saline) was started intravenously using a programmable syringe pump (Pilote IEC, Fresenius-Vial, Bressins, France) at a rate of 0.15 μg/kg/min.
Environmental cultures were obtained from potential sources such as sinks, soaps, different surfaces (incubators, perfusors), medical equipment (oxygen tubes, oxygen masks, feeding syringes, breast pumps) and opened vials and bottles (antibiotics, saline and glucose solutions).
The generator is eluted with a syringe pump directly into the SomaKit vial.
Anesthesia was induced and maintained with continuous infusion of propofol and remifentanil using a target control infusion pump (Orchestra® Base Primea, Fresenius Vial, Brezins, France).
